Bacterial superantigens
- PMID: 12930353
- PMCID: PMC1808794
- DOI: 10.1046/j.1365-2249.2003.02203.x
Bacterial superantigens
Figures



Similar articles
-
Superantigens: structure and relevance to human disease.Proc Soc Exp Biol Med. 1996 Jun;212(2):99-109. doi: 10.3181/00379727-212-43996. Proc Soc Exp Biol Med. 1996. PMID: 8650257 Review.
-
Streptococcal superantigens: categorization and clinical associations.Trends Mol Med. 2014 Jan;20(1):48-62. doi: 10.1016/j.molmed.2013.10.004. Epub 2013 Nov 6. Trends Mol Med. 2014. PMID: 24210845 Review.
-
Superantigens in dermatology.J Am Acad Dermatol. 2011 Mar;64(3):455-72; quiz 473-4. doi: 10.1016/j.jaad.2010.03.044. J Am Acad Dermatol. 2011. PMID: 21315950 Review.
-
Bacterial superantigens--mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases.Microbiol Immunol. 1994;38(4):245-56. doi: 10.1111/j.1348-0421.1994.tb01772.x. Microbiol Immunol. 1994. PMID: 7935042 Review. No abstract available.
-
[Superantigens and their behavior in the immune response].Rev Alerg Mex. 1996 Jan-Feb;43(1):13-7. Rev Alerg Mex. 1996. PMID: 8901035 Review. Spanish.
Cited by
-
Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity.Infect Immun. 2010 Apr;78(4):1728-39. doi: 10.1128/IAI.01079-09. Epub 2010 Feb 1. Infect Immun. 2010. PMID: 20123710 Free PMC article.
-
Proinflammatory mediators of toxic shock and their correlation to lethality.Mediators Inflamm. 2010;2010:517594. doi: 10.1155/2010/517594. Epub 2010 Jun 16. Mediators Inflamm. 2010. PMID: 20634937 Free PMC article.
-
Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies.Pathogens. 2022 Jun 2;11(6):642. doi: 10.3390/pathogens11060642. Pathogens. 2022. PMID: 35745496 Free PMC article. Review.
-
Superantigen SpeA attenuates the biofilm forming capacity of Streptococcus pyogenes.J Microbiol. 2019 Jul;57(7):626-636. doi: 10.1007/s12275-019-8648-z. Epub 2019 Jun 27. J Microbiol. 2019. PMID: 31054134
-
Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.Virulence. 2017 Oct 3;8(7):1148-1159. doi: 10.1080/21505594.2016.1267894. Epub 2016 Dec 7. Virulence. 2017. PMID: 27925510 Free PMC article.
References
-
- Bohach G, Fast D, Nelson R, et al. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17:251–72. - PubMed
-
- Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990;248:705–11. - PubMed
-
- Dellabona P, Peccoud J, Kappler J, et al. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell. 1990;62:1115–21. - PubMed
-
- Herman A, Kappler J, Marrack P, et al. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol. 1991;9:745–72. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources